Trends in P2Y12 inhibitor use after acute coronary syndromes: insights from the ProACS registry

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Ana Ines Aguiar Neves

Unidade local de Saude Gaia/Espinho EPE, Vila Nova de Gaia (Portugal)

9 More presentations in this session

Presentation thumbnail

Discussant - Thrombosis, platelets, and coagulation in coronary disease

Presentation thumbnail

Tissue factor, a membrane-associated biomarker of platelet activation, predicts 5-year cardiovascular mortality in coronary artery disease patients

Professor M. Camera (Milan, IT)

Presentation thumbnail

Impact of fibrin and atheroma on prognosis in acute coronary syndrome: Insights from thrombectomy specimens

Mr H. Nohara (Sakai, JP)

Abstract Slides Video

Presentation thumbnail

Thrombus aspiration reduces myocardial infarct size in patients with STEMI and high thrombus burden

Doctor A. Del Torto (Milano, IT)

Abstract Slides Video

Presentation thumbnail

Is spontaneous pre-hospital coronary reperfusion in STEMI safe ?

Doctor P. Meunier (Montpellier, FR)

Abstract Slides Video

Access the full session

Session thumbnail

New perspectives in cardiology (4) - Thrombosis, platelets, and coagulation in coronary disease

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

Comparative effectiveness of prasugrel and ticagrelor among patients undergoing contemporary PCI: insights from the BMC2 registry

Congress Session

Antiplatelet therapy: novel approaches for acute coronary syndrome and percutaneous coronary intervention

Congress Session

Oral antiplatelet therapy after acute coronary syndromes: how to choose the best regimen and the optimum duration

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources